VIEMED HEALTHCARE, INC. (VMD)

Director Dobbs Randy E. 🟡 adjusted position in 12.7K shares (3 derivative) of VIEMED HEALTHCARE, INC. (VMD) at $8.94 Transaction Date: Aug 17, 2026 | Filing ID: 000003

Register to leave comments

  • News bot Aug. 19, 2026, 8:30 p.m.

    🔍 Dobbs Randy E. (Director)

    Company: VIEMED HEALTHCARE, INC. (VMD)

    Report Date: 2026-08-17

    Transaction Summary:

    • Total transactions: 6
    • Derivative instruments: 3
    • Holdings reported: 0
    • Total shares acquired: 37,802
    • Total shares sold: 25,145

    Detailed Transactions and Holdings:

    • Acquired 16,763 shares of Common Shares (Direct)
      Date: 2026-08-19 | Code: M | equity_swap_involved: 0 | shares_owned_after: 142,253.00 | transaction_form_type: 4 | Footnotes: F1
    • Acquired 4,191 shares of Common Shares (Direct)
      Date: 2026-08-19 | Code: M | equity_swap_involved: 0 | shares_owned_after: 146,444.00 | transaction_form_type: 4 | Footnotes: F2
    • Sold 4,191 shares of Common Shares at $8.94 per share (Direct)
      Date: 2026-08-19 | Code: D | equity_swap_involved: 0 | shares_owned_after: 142,253.00 | transaction_form_type: 4 | Footnotes: F3
    • Sold 16,763 shares of Restricted Stock Units (Derivative)
      Date: 2026-08-19 | Code: M | equity_swap_involved: 0 | transaction_form_type: 4 | Footnotes: F1, F4, F4
    • Sold 4,191 shares of Phantom Share Units (Derivative)
      Date: 2026-08-19 | Code: M | equity_swap_involved: 0 | transaction_form_type: 4 | Footnotes: F2, F5, F5
    • Acquired 16,848 shares of Restricted Stock Units (Derivative)
      Date: 2026-08-17 | Code: A | Expires: 2027-08-17 | equity_swap_involved: 0 | shares_owned_after: 16,848.00 | transaction_form_type: 4 | Footnotes: F1, F6

    Footnotes:

    • F1: Each Restricted Stock Unit (RSU) represents a contingent right to receive one common share.
    • F2: Represents vesting of cash-settled phantom shares granted under the Issuer's Phantom Share Unit Plan. Each phantom share is the economic equivalent of one Company common share. The settlement of the phantom shares for cash is reported on this Form 4 as a disposition of the phantom shares being settled in exchange for the acquisition of the underlying Company common shares, and a simultaneous disposition of the underlying Company common shares to the Company for cash.
    • F3: Per share value is based on the market closing price of the common shares for August 19, 2026.
    • F4: On August 19, 2025, the reporting person was granted Restricted Stock Units which vest on August 19, 2026.
    • F5: On August 19, 2025, the reporting person was granted Phantom Share Units which vest on August 19, 2026.
    • F6: Restricted Stock Units (RSUs) granted to reporting person on August 17, 2026, which vest on the first anniversary of the grant date.